Metody podtrzymywania ciąży zagrożonej przedwczesnym porodem

• Autorzy: Dobrzynski A. , Max A. , Jurka P.

Warianty tytułu

EN

Methods of prolonging a pregnancy threatened with preterm labour

• Języki publikacji: PL

Abstrakty

EN

Both prolonged and shortened pregnancies carry the risk of increased mortality of the offspring. The main causes of early delivery are genetic factors, bacterial and viral infections, corpus luteum insufficiency and pathologies of the placenta. Antepartum luteolysis is due to the activity of prostaglandin F2α. A decrease in the progesterone concentration activates the sensitivity of the uterine muscles to oxytocin. Calcium ions move into the myocytes and bind to calmodulin, starting enzymatic reactions necessary for muscle contraction. Oxytocin promotes prostaglandin F2α release. Cholesterol and magnesium stimulate the binding of oxytocin to its receptors. A premature delivery is caused by a disorder of the balance between contractility and relaxation of the myometrium, which is regulated by many signalling pathways. Birth in humans can be postponed by the use of many different tocolytic medications, β-adrenergic drugs (ritodrine, hexoprenaline, fenoterol, terbutaline), magnesium salts, prostaglandin synthesis inhibitors (indomethacin, naproxen), pentoxifylline, metoprolol, calcium antagonists – calcium channel blockers (nifedipine), oxytocine antagonists (atosiban), nitric oxide donors (nitroglycerin) as well as progesterone and its synthetic analogs. In dogs and cats, in the presence of endogenous hormone deficiency, progesterone and its derivatives (gestagens) are recommended. In small animals with the risk of premature delivery, terbutaline has successfully been used. Premature delivery is a serious problem in both human and veterinary medicine, and experience from human medicine is being gradually introduced into veterinary practice.

Słowa kluczowe

PL

psy; koty; rozrod zwierzat; ciaza; porody przedwczesne; ryzyko; przyczyny; zapobieganie; podtrzymanie ciazy; metody; leczenie farmakologiczne; progesteron; terbutalina; zastosowanie

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2016
• Tom: 72
• Numer: 08
• Opis fizyczny: s.479-483,bibliogr.

Twórcy

autor

Dobrzynski A.

• Katedra Chorób Małych Zwierząt z Kliniką, Wydział Medycyny Weterynaryjnej, Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, ul.Nowoursynowska 159c, 02-776 Warszaw

autor

Max A.

• Katedra Chorób Małych Zwierząt z Kliniką, Wydział Medycyny Weterynaryjnej, Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, ul.Nowoursynowska 159c, 02-776 Warszaw

autor

Jurka P.

• Katedra Chorób Małych Zwierząt z Kliniką, Wydział Medycyny Weterynaryjnej, Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, ul.Nowoursynowska 159c, 02-776 Warszaw

Bibliografia

• Aissi A., Slimani C.: Ultrasonographic appearance of the gestational structures throughout pregnancy in bitches. Am. J. Anim. Vet. Sci. 2008, 3, 32-35.
• Beccaglia M., Luvoni G. C.: Prediction of parturition in dogs and cats: accuracy at different gestational ages. Reprod. Domest. Anim. 2012, 47 Suppl. 6, 194-196.
• Blencowe H., Cousens S., Chou D., Oestergaard M., Say L., Moller A. B., Kinney M., Lawn J.: Born too soon: the global epidemiology of 15 million preterm births. Reprod. Health 2013, 10, 2. doi: 10.1186/1742-4755-10-S1-S2.
• Borthwick A. D., Liddle J.: The design of orally bioavailable 2, 5-diketopiperazine oxytocin antagonists: from concept to clinical candidate for premature labor. Med. Res. Rev. 2011, 31, 576-604.
• Bresciani K. D., Costa A. J., Toniollo G. H., Luvizzoto M. C., Kanamura C. T., Moraes F. R., Perri S. H., Gennari S. M.: Transplacental transmission of Toxoplasma gondii in reinfected pregnant female canines. Parasitol. Res. 2009, 104, 1213-1217.
• Bresciani K. D., Costa A. J., Toniollo G. H., Sabatini G. A., Moraes F. R., Paulillo A. C., Ferraudo A. S.: Experimental toxoplasmosis in pregnant bitches. Vet. Parasitol. 1999, 86, 143-145.
• Brizot M. L., Hernandez W., Liao A. W., Bittar R. E., Francisco R. P., Krebs V. L., Zugaib M.: Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study. Am. J. Obstet. Gynecol. 2015, doi: 10.1016/j.ajog.2015.02.021.
• Buxton I. L.: Regulation of uterine function: a biochemical conundrum in the regulation of smooth muscle relaxation. Mol. Pharmacol. 2004, 65, 1051-1059.
• Buxton I. L., Heyman N., Wu Y. Y., Barnett S., Ulrich C.: A role of stretch-activated potassium currents in the regulation of uterine smooth muscle contraction. Acta Pharmacol. Sin. 2011, 758-764.
• Chamberlain D. M., Docton F. L., Cole C. R.: Toxoplasmosis, II. Intra-uterine infection in dogs, premature birth and presence of organisms in milk. Proc. Soc. Exp. Biol. Med. 1953, 82, 198-200.
• Concannon P. W., McCann J. P., Temple M.: Biology and endocrinology of ovulation, pregnancy and parturition in the dog. J. Reprod. Fertil. Suppl. 1989, 39, 3-25.
• Cushing T. L., Lopate C., Schlafer D. H.: Benign placental mass with fetal growth retardation in a bull mastiff. J. Comp. Pathol. 2011, 145, 352-354.
• Davidson A. P.: Tocodynamometry detects preterm labor in the bitch prior to luteolysis. Proc. 7th Intern. Symp. Canine and Feline Reprod. – ISCFR, Whistler, Canada 2012, s. 12-14.
• Franczak A., Ciereszko R., Kotwica G.: Oxytocin (OT) action in uterine tissues of cyclic and early pregnant gilts: OT receptors concentration, prostaglandin F(2)alpha secretion, and phosphoinositide hydrolysis. Anim. Reprod. Sci. 2005, 88, 325-339.
• French/Australian Atosiban Investigators Group: Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001, 98, 177-185.
• Fuchs A. R., Fuchs F., Husslein P., Soloff M. S.: Oxytocin receptors in the human uterus during pregnancy and parturition. Am. J. Obstet. Gynecol. 1984, 150, 734-741.
• Gimpl G., Fahrenholz F.: The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81, 629-683.
• Görlinger S., Galac S., Kooistra H. S., Okkens A. C.: Hypoluteoidism in a bitch. Theriogenology 2005, 64, 213-219.
• Gram A., Boos A., Kowalewski M. P.: Uterine and placental expression of canine oxytocin receptor during pregnancy and normal and induced parturition. Reprod. Domest. Anim. 2014, 49 Suppl. 2, 41-49.
• Johnson C. A.: High-risk pregnancy and hypoluteoidism in the bitch. Theriogenology 2008, 70, 1424-1430.
• Kimber-Trojnar Ż., Leszczyńska-Gorzelak B., Marciniak B., Bartosiewicz J., Oleszczuk J.: Leczenie tokolityczne w zagrażającym porodzie przedwczesnym. Ginekol. Pol. 2010, 81, 120-124.
• Kimura T., Takemura M., Nomura S., Nobunaga T., Kubota Y., Inoue T, Hashimoto K., Kumazawa I., Ito Y., Ohashi K., Koyama M., Azuma C., Kitamura Y., Saji F.: Expression of oxytocin receptor in human pregnant myometrium. Endocrinol. 1996, 137, 780-785.
• Kimura T., Tanizawa O., Mori K., Brownstein M. J., Okayama H.: Structure and expression of a human oxytocin receptor. Nature 1992, 356, 526-529.
• Kis A., Bence M., Lakatos G., Pergel E., Turcsán B., Pluijmakers J., Vas J., Elek Z., Brúder I., Földi L., Sasvári-Székely M., Miklósi A., Rónai Z., Kubinyi E.: Oxytocin receptor gene polymorphisms are associated with human directed social behavior in dogs (Canis familiaris). PLoS One. 2014,15; 9, doi: 10.1371/journal.pone.0083993.
• Klarenbeek M., Okkens A. C., Kooistra H. S., Mol J. A., Bevers M. M., Taverne M. A.: Plasma oxytocin concentrations during late pregnancy and parturition in the dog. Theriogenology 2007, 68, 1169-1176.
• Kowalewski M. P., Beceriklisoy H. B., Pfarrer C., Aslan S., Kindahl H., Kücükaslan I., Hoffmann B.: Canine placenta: a source of prepartal prostaglandins during normal and antiprogestin-induced parturition. Reproduction 2010, 139, 655-664.
• Lopate C.: Estimation of gestational age and assessment of canine fetal maturation using radiology and ultrasonography: a review. Theriogenology 2008, 70, 397-402.
• Martinez de Tejada B., Karolinski A., Ocampo M. C., Laterra C., Hösli I., Fernández D., Surbek D., Huespe M., Drack G., Bunader A., Rouillier S., López de Degani G., Seidenstein E., Prentl E., Antón J., Krähenmann F., Nowacki D., Poncelas M., Nassif J. C., Papera R., Tuma C., Espoile R., Tiberio O., Breccia G., Messina A., Peker B., Schinner E., Mol B. W., Kanterewicz L., Wainer V., Boulvain M., Othenin-Girard V., Bertolino M. V., Irion O.: 4P trial group: Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. B.J.O.G. 2015, 122, 80-91.
• Marx P., Arany A., Rónai Z., Antal P., Sasvári-Szekely M.: Genetic variability of the oxytocine receptor: an in silico study [in Hungarian]. Neuropsychopharmacol. Hung. 2011, 13(3), 139-144.
• Michel E., Spörri M., Ohlerth S., Reichler I. M.: Prediction of parturition date in the bitch and queen. Reprod. Domest. Anim. 2011, 46, 926-932.
• Mitsuya K., Singh N., Sooranna S. R., Johnson M. R., Myatt L.: Epigenetics of human myometrium: DNA methylation of genes encoding contraction-associated proteins in term and preterm labor. Biol. Reprod. 2014, 90, 98. doi: 10.1095/biolreprod.113.113209.
• Otaibi M. A.: The physiological mechanism of uterine contraction with emphasis on calcium ion. Calcium Signaling 2014, 1, 70-75.
• Reinheimer T. M.: Barusiban suppresses oxytocin-induced preterm labour in non-human primates. B.M.C. Pregnancy Childbirth 2007, 7 Suppl., 1:S15.
• Robinson R. S., Mann G. E., Lamming G. E., Wathes D. C.: Expression of oxytocin, oestrogen and progesterone receptors in uterine biopsy samples throughout the oestrous cycle and early pregnancy in cows. Reproduction 2001, 122, 965-979.
• Romero R.: Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last. Womens Health (Lond. Engl.) 2011, 7, 501-504.
• Saleh S. S., Al-Ramahi M. Q., Al Kazaleh F. A.: Atosiban and nifedipine in the suppression of pre-term labour: a comparative study. J. Obstet. Gynaecol. 2013, 33, 43-45.
• Shim J. Y., Park Y. W., Yoon B. H., Cho Y. K., Yang J. H., Lee Y., Kim A.: Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women. B.J.O.G. 2006, 113, 1228-1234.
• Siemieniuch M. J., Jursza E., Szóstek A. Z., Zschockelt L., Boos A., Kowalewski M. P.: Placental origin of prostaglandin F2α in the domestic cat. Mediators Inflamm. 2014. doi: 10.1155/2014/364787.
• Siemieniuch M. J., Mlynarczuk J. J., Skarzynski D. J., Okuda K.: Possible involvement of oxytocin and its receptor in the local regulation of prostaglandin secretion in the cat endometrium. Anim. Reprod. Sci. 2011, 123(1-2), 89-97.
• Slager J., Lynne S.: Treatment options and recommendations to reduce preterm births in women with short cervix. J Midwifery Womens Health. 2012, 57 Suppl. 1:S12-8. doi: 10.1111/j.1542-2011.2012.00210.x.
• Socha P., Janowski T.: Predicting the parturition date in yorkishire terrier and golden retriever bitches using ultrasonographic fetometry. Bull. Vet. Inst. Pulawy 2011, 55, 71-75.
• Sotiriadis A., Papatheodorou S., Makrydimas G.: Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis. Ultrasound Obstet. Gynecol. 2012, 40, 257-266.
• Thornton S., Goodwin T. M., Greisen G., Hedegaard M., Arce J. C.: The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial. Am. J. Obstet. Gynecol. 2009, 200. doi: 10.1016/j.ajog.2009.01.015.
• Tita A. T., Rouse D. J.: Progesterone for preterm birth prevention: an evolving intervention. Am. J. Obstet. Gynecol. 2009, 200, 219-224.
• Tsatsaris V., Carbonne B., Cabrol D.: Atosiban for preterm labour. Drugs 2004, 64, 375-382.
• Ulrich C., Quilici D. R., Schlauch K. A., Buxton I. L.: The human uterine smooth muscle S-nitrosoproteome fingerprint in pregnancy, labor, and preterm labor. Am. J. Physiol. Cell Physiol. 2013, 15, 305, 803-816.
• Veiga G. A., Milazzotto M. P., Nichi C. F., Silva L. C., Angrimaniu D. S., Vannucchi C. I.: Gene expression of estrogen and oxytocin receptors in the uterus of pregnant and parturient bitches. Braz. J. Med. Biol. Res. 2015, 48, 339-343.
• Vogel J. P., Nardin J. M., Dowswell T., West H. M., Oladapo O. T.: Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database Syst. Rev. 2014. doi: 10.1002/14651858.CD006169
• Wanke M. M., Loza M. E., Rebuelto M.: Progestin treatment for infertility in bitches with short interestrus interval. Theriogenology 2006, 66, 1579-1582.
• Wiebe V. J., Howard J. P.: Pharmacologic advances in canine and feline reproduction. Top Companion Anim. Med. 2009, 24, 71-99.
• Wielgoś M., Bomba-Opoń D. A.: Tokoliza w porodzie przedwczesnym – aktualne wytyczne. Ginekol. Pol. 2014, 85, 332-334.
• Wood S., Ross S., Tang S., Miller L., Sauve R., Brant R.: Vaginal progesterone to prevent preterm birth in multiple pregnancy: a randomized controlled trial. J. Perinat. Med. 2012, 40, 593-599.
• Worldwide Atosiban versus Beta-agonists Study Group: Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. B.J.O.G. 2001, 108, 133-142.
• Yuan W., López Bernal A.: Cyclic A.M.P. signalling pathways in the regulation of uterine relaxation. BMC Pregnancy Childbirth. 2007, 7, Suppl. 1, S10.

Identyfikatory

DOI

10.21521/mw.5550